CoChat
Sign Up
Cited by 3Neuroprotection in Cerebral IschemiaHeterocyclic Compound Synthesis and BioactivityNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Design, synthesis and biological evaluation of indoline derivatives as multifunctional agents for the treatment of ischemic stroke

Open access
Du, Shuaishuai, Jin, Fan, Li, Jiaming, Ma, Xiaodong, Wang, Hongwei, Qian, Shihu·2022·Medicinal Chemistry Research
DOI 10.1007/s00044-022-02875-1

Published version of a preprint

Open this paper in CoChat — free accountOpen PDF

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00044-022-02875-1

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 2 references

Research works printed but not linked: 35

  1. Wu J, Wang B, Li M, Shi YH, Wang C, Kang YG. Network pharmacology identification of mechanisms of cerebral ischemia injury amelioration by Baicalin and Geniposide. Eur J Pharmacol 2019;859:172484 https://doi.org/10.1016/j.ejphar.2019.172484. · DOI
  2. Sommer, Clemens J. Ischemic stroke: experimental models and reality. Acta Neuropathol. 2017;133:245–61. https://doi.org/10.1007/s00401-017-1667-0 · DOI · Paper page
  3. Deb P, Sharma S, Hassan KM. Pathophysiologic mechanisms of acute ischemic stroke: an overview with emphasis on therapeutic significance beyond thrombolysis. Pathophysiology. 2010;17:197–18. https://doi.org/10.1016/j.pathophys.2009.12.001 · DOI
  4. Jung S, Gralla J, Fischer U, Mono ML, Weck A, Ludi R, et al. Safety of endovascular treatment beyond the 6-h time window in 205 patients. Eur J Neurol. 2013;20:865–71. https://doi.org/10.1111/ene.12069 · DOI
  5. Ovbiagele B, Kidwell CS, Starkman S, Saver JL. Potential role of neuroprotective agents for the treatment of patients with acute ischemic stroke. Curr Treat Option Ne. 2003;3:9–20. https://doi.org/10.1007/s11940-003-0027-7 · DOI
  6. Luo Y, Tang H, Li H, Zhao R, Huang QH, Liu JM. Recent advances in the development of neuroprotective agents and therapeutic targets in the treatment of cerebral ischemia. Eur J Med Chem. 2019;162:132–46. https://doi.org/10.1016/j.ejmech.2018.11.014 · DOI
  7. Uzdensky AB. Photothrombotic stroke as a model of ischemic stroke. Transl Stroke Res. 2018;9:437–51. https://doi.org/10.1007/s12975-017-0593-8 · DOI
  8. Tewes B, Frehland B, Schepmann D, Schmidtke KU, Winckler T, Wunsch B. Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols. Bioorg Med Chem. 2010;18:8005–15. https://doi.org/10.1016/j.bmc.2010.09.026 · DOI
  9. Nakase T, Yamazaki T, Ogura N, Suzuki A, Nagata K. The impact of inflammation on the pathogenesis and prognosis of ischemic stroke. J Neurol Sci. 2008;271:104–9. https://doi.org/10.1016/j.jns.2008.03.020 · DOI
  10. Terao S, Yilmaz G, Stokes KY, Russell J, Ishikawa M, Kawase T, et al. Blood cell-derived RANTES mediates cerebral microvascular dysfunction, inflammation and tissue injury after focal ischemia-reperfusion. Stoke. 2008;39:2560–70. https://doi.org/10.1161/strokeaha.107.513150 · DOI
  11. Pei J, You X, Fu Q. Inflammation in the pathogenesis of ischemic stroke. Front Biosci (Landmark Ed). 2015;20:772–83. https://doi.org/10.2741/4336 · DOI
  12. Zeeli S, Weill T, Finkin-Groner E, Bejar C, Melamed M, Furman S, et al. Synthesis and biological evaluation of derivatives of indoline as highly potent antioxidant and antiinflammatory agents. J Med Chem. 2018;61:4004–19. https://doi.org/10.1021/acs.jmedchem.8b00001 · DOI
  13. Doyle KP, Simon RP, Stenzel-Poore MP. Mechanisms of ischemic brain damage. Nueropharmacology. 2008;55:310–8. https://doi.org/10.1016/j.neuropharm.2008.01.005 · DOI
  14. Benveniste H, Drejer J, Schousboe A, Diemer NH. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem. 1984;43:1369–74. https://doi.org/10.1111/j.1471-4159.1984.tb05396.x · DOI
  15. Lai TW, Zhang S, Wang YT. Excitotoxicity and stroke: idenfying novel targets for neuroprotection. Prog Neurobiol 2014;115:157–88. https://doi.org/10.1016/j.pneurobio.2013.11.006 · DOI · Paper page
  16. Menniti F, Chenard B, Collins M, Ducat M, White F. CP-101,606, a potent neuroprotectant selective for forebrain neurons. Eur J Pharm. 1997;331:117–26. https://doi.org/10.1016/S0014-2999(97)10092-9 · DOI
  17. Henter ID, De Sousa RT, Zarate CA. Glutamatergic modulators in depression. Harv Rev Psychiatry. 2018;26:307–19. https://doi.org/10.1097/hrp.0000000000000183 · DOI
  18. Machado-Vieira R, Henter ID, Zarate CA. New targets for rapid antidepressant action. Prog Neurobiol. 2017;152:21–37. https://doi.org/10.1016/j.pneurobio.2015.12.001 · DOI
  19. Stroebel D, Buhl DL, Knafels JD, Chanda PK, Gree M, Sciabola S, et al. A novel binding mode reveals two distinct classes of NMDA receptor GluN2B-selective antagonists. Mol Pharm. 2016;89:541–51. https://doi.org/10.1124/mol.115.103036 · DOI
  20. Karakas E, Simorowski N, Furukawa H. Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors. Nature. 2011;475:249–53. https://doi.org/10.1038/nature10180 · DOI
  21. Li J, Nie CB, Qian Y, Hu J, Li QF, Wang Q, et al. Design, synthesis and biological evaluation of novel 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole triazole derivatives as potent TRPV1 antagonists. Eur J Med Chem. 2019;178:433–45. https://doi.org/10.1016/j.ejmech.2019.06.007 · DOI
  22. Estopina-Duran S, Mclean EB, Donnelly LJ, Hockin BM, Taylor JE. Arylboronic acid catalyzed C-alkylation and allylation reactions using benzylic alcohols. Org Lett. 2020;22:7547–51. https://doi.org/10.1021/acs.orglett.0c02736 · DOI
  23. Chen ZW, Lin HX, Han J, Fang DM, Wang M, Liao J. Enantioselective copper-catalyzed electrophilic sulfenylation of cyclic imino esters. Org Lett 2021;23:1946–50. https://doi.org/10.1021/acs.orglett.1c03464 · DOI
  24. Seliger J, Oestreich M. Dynamic kinetic resolution of alcohols by enantioselective silylation enabled by two orthogonal transition‐metal catalysts. Angew Chem Int Ed. 2020;60:247–51. https://doi.org/10.1002/anie.202010484 · DOI
  25. Robert Z, Baumeister S, Dirk S, Wunsch B. Pyridine bioisosteres of potent GluN2B subunit containing NMDA receptor antagonists with benzo[7]annulene scaffold. Eur J Med Chem. 2018;157:397–04. https://doi.org/10.1016/j.ejmech.2018.08.003 · DOI
  26. Temme L, Bechthold E, Schreiber JA, Gawaskar S, Schepmann D, Robaa D, et al. Negative allosteric modulators of the GluN2B NMDA receptor with phenylethylamine structure embedded in ring-expanded and ring-contracted scaffolds. Eur J Med Chem. 2020;190:112138 https://doi.org/10.1016/j.ejmech.2020.112138 · DOI
  27. Chaffey H, Chazot PL. NMDA receptor subtypes: structure, function and therapeutics. Anaesth Crit Care. Pain Med. 2008;19:183–01. https://doi.org/10.1016/j.cacc.2008.05.004. · DOI
  28. Tang N, Wu JH, Zhu H, Yan HL, Guo Y, Cai Y, et al. Genetic mutation of GluN2B protects brain cells against stroke damages. Mol Neurobiol. 2018;55:2979–90. https://doi.org/10.1007/s12035-017-0562-y · DOI
  29. Zhang BY, Wang GR, Ning WH, Liu J, Yang S, Shen Y, et al. Electroacupuncture pretreatment elicits tolerance to cerebral ischemia/reperfusion through inhibition of the GluN2B/m-Calpain/p38 MAPK Proapoptotic Pathway. Neural Plast. 2020;2020:1–14. https://doi.org/10.1155/2020/8840675 · DOI
  30. Huang L, Wang J, Chen L, Zhu C, Wu SB, Chu SH, et al. Design, synthesis, and evaluation of NDGA analogues as potential anti-ischemic stroke agents. Eur J Med Chem. 2018;143:1165–73. https://doi.org/10.1016/j.ejmech.2017.09.028 · DOI
  31. Abdel-Salam OM, Baiuomy AR, EI-Shenawy SM, Aribid MS. The anti-inflammatory effects of the phosphodiesterase inhibitor pentoxifylline in the rat. Pharmacol Res 2003;47:331–40. https://doi.org/10.1016/S1043-6618(03)00002-1 · DOI
  32. Gitto R, Luca LD, Ferro S, Buemi MR, Russo E, Sarro GD, et al. Synthesis and biological characterization of 3-substituted-1H-indoles as ligands of GluN2B-containing N-methyl-D-aspartate receptors. Bioorgan Med Chem. 2014;22:1040–8. https://doi.org/10.1016/j.bmc.2013.12.040 · DOI
  33. Hu H, Li Z, Zhu X, Li RH, Lin JM, Peng J, et al. Gua Lou Gui Zhi decoction suppresses LPS-induced activation of the TLR4/NF-κB pathway in BV-2 murine microglial cells. Int J Mol Med. 2013;31:1327–32. https://doi.org/10.3892/ijmm.2013.1331 · DOI
  34. Durukan A, Tatlisumak T. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharm Blochem Be. 2007;87:179–97. https://doi.org/10.1016/j.pbb.2007.04.015 · DOI
  35. Ballabh P, Braun A, Nedergaard M. The blood–brain barrier: an overview Structure, regµlation, and clinical imPlications. Neurobiol Dis. 2004;16:1–13. https://doi.org/10.1016/j.nbd.2003.12.016 · DOI

Metadata

Authors
Du, S., Jin, F., Li, J., Ma, X., Wang, H., & Qian, S.
Affiliations
Anhui University of Traditional Chinese Medicine (CN)
Corresponding author
  • Li, Jiaming
  • Ma, Xiaodong
ORCID
Venue
Medicinal Chemistry Research
Publisher
Springer Science and Business Media LLC
Published
2022-04-13
Volume
31
Issue
5
Pages
805-818
ISSN
  • 1054-2523 (ISSN-L)
  • 1554-8120
DOI
10.1007/s00044-022-02875-1
OpenAlex
W4225655087
Cited by
3
References
2
Citations by year
2026: 2 · 2023: 1
FWCI
0.09
Type
journal article
Language
en
Open access
Licence
Locations
  • Medicinal Chemistry Research (publishedVersion)
  • Research Square (acceptedVersion, cc-by)
Funders
  • University Natural Science Research Project of Anhui Province (KJ2020A0412)
  • National Science and Technology Infrastructure Program (2020HZ062)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
  • Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
indoline derivatives, ischemic stroke, neuroprotection, antioxidant activity, oxygen-glucose deprivation/reoxygenation, neuroinflammation, inflammatory cytokines, middle cerebral artery occlusion, cerebral infarction, ifenprodil

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review